Skip to main content

Table 3 Recommendations for change to improve wider research practice around P/FS

From: Recommendations for optimising pilot and feasibility work in surgery

 

Recommendation

Further detail

Issues to consider

Education

Improved guidance on designing and conducting PAFS

Multi-disciplinary team-led, consensus-based guidance endorsed by funders, regulatory bodies and journals

How to operationalise theoretical/conceptual guidance specifically for application by clinicians in practice

Grassroots training for surgeons from earlier in their career

Training in trials methodology through courses, conferences, publication and guidelines

How to ensure effective collaboration between clinicians and methodologists

Collaboration

Collaboration of surgeons with methodologists and CTUs

Working closely with methodologists and CTUs from earlier in the research process to ensure the future main trial is in sight

Practicalities of funding collaborations

How to optimise PPI when designing and conducting PAFS for surgical trials

Accessibility of CTUs and methodology support

Highlight where to go/who to ask for assistance in each geographical area in the new guidance

Consider what level of method support is enough for PAFS

Funding

Improved efficiency of funding structure

More joined-up funding so no lag time between successful PAFS and main trial

Consider more programmes offering staged funding like NIHR PGfAR to improve efficiency and reduce waste

How to associate decision-making between local RfPB committees and national funders of definitive trials

Raising the profile of the importance of funding surgical studies

To achieve proportional funding

More surgeons on funding panels

Regulatory requirements for industry to contribute to surgical research

How to promote surgical involvement on funding panels

Dissemination

Funder requirement to publish PAFS

Publication in journals and/or through publicly available funder reports

How to fund process of publication

Journal editors stop publishing underpowered RCTs as PAFS or PAFS as underpowered RCTs

Both wrong. Educate through guidance

Consider involving editors of surgical journals in the process for producing guidance

Academic institutions to value PAFS as potentially essential for main trial development

PAFS may not be 3 or 4* REF rated alone, but should be recognised for the often pivotal role they play in the success of the definitive trial. If academic institutions do not value PAFS, researchers will not value disseminating their findings

How to engage academic institutions in considering the value of PAFS

  1. Key: PAFS pilot and feasibility studies, CTUs clinical trials units, PPI patient and public involvement, NIHR National Institute for Health and Care Research, PGfAR Programme Grants for Applied Research, RfPB Research for Patient Benefit, RCTs randomised controlled trials, REF Research Excellence Framework